Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Advanced therapy medicinal product manufacturing under the hospital exemption and other exemption pathways in seven European Union countries

Published:2020-10 Issue:10 Volume:22 Page:592-600
ISSN:1465-3249
Container-title:Cytotherapy
language:en
Short-container-title:Cytotherapy

Author:

Coppens Delphi G.M.,Hoekman Jarno,De Bruin Marie L.,Slaper-Cortenbach Ineke C.M.,Leufkens Hubert G.M.,Meij Pauline,Gardarsdottir Helga

Publisher

Elsevier BV

Subject

Cancer Research,Transplantation,Cell Biology,Genetics(clinical),Oncology,Immunology,Immunology and Allergy

Reference46 articles.

1. Challenges with advanced therapy medicinal products and how to meet them;Schneider;Nat Rev Drug Discov,2010

2. Cell-based therapeutics: the next pillar of medicine;Fischbach;Sci Transl Med,2013

3. History of gene therapy;Wirth;Gene,2013

4. Manufacturing, characterization and control of cell-based medicinal products: challenging paradigms toward commercial use;Salmikangas;Regen Med,2015

5. Hurdles in clinical implementation of academic advanced therapy medicinal products: a national evaluation;de Wilde;Cytotherapy,2016

Cited by 22 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Polish regulatory system regarding ATMP hospital exemptions;Frontiers in Immunology;2024-05-13

2. Zastosowanie produktu leczniczego terapii zaawansowanej - wyjątku szpitalnego a eksperyment leczniczy;Diametros;2024-04-26

3. Integrating Artificial Intelligence for Academic Advanced Therapy Medicinal Products: Challenges and Opportunities;Applied Sciences;2024-02-05

4. Together for the greater goods: legitimising social innovation in the pharmaceutical field;Innovation: The European Journal of Social Science Research;2024-01-02

5. Clinical research and drug regulation in the challenging times of individualized therapies: A pivotal role of clinical pharmacology;Pharmacological Research;2024-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3